5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Guided Therapeutics's 5-Year ROIIC % for the quarter that ended in Dec. 2023 was 55.72%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Guided Therapeutics's 5-Year ROIIC % or its related term are showing as below:
GTHP's 5-Year ROIIC % is ranked better than 88.48% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 0.43
vs GTHP: 55.72
Guided Therapeutics 5-Year ROIIC % Historical Data
The historical data trend for Guided Therapeutics's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Guided Therapeutics's 5-Year ROIIC %
For the Medical Devices subindustry, Guided Therapeutics's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guided Therapeutics's 5-Year ROIIC % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Guided Therapeutics's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Guided Therapeutics's 5-Year ROIIC % falls into.
Guided Therapeutics 5-Year ROIIC % Calculation
Guided Therapeutics's 5-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:
5-Year ROIIC %
=
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
5-Year Incremental Invested Capital**
=
( -3.457 (Dec. 2023) - -1.548 (Dec. 2018) )
/
( 2.52 (Dec. 2023) - 5.946 (Dec. 2018) )
=
-1.909
/
-3.426
=
55.72%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Guided Therapeutics 5-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of Guided Therapeutics's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Guided Therapeutics (Guided Therapeutics) Business Description
Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GTHP has been successfully added to your 